Insights
Search Results
Client Highlights
5.13.26
Wilson Sonsini Advises Recursive on $650 Million Series A Funding at a $4.65 Billion Valuation
On May 13, 2026, Recursive, an AI start-up dedicated to advancing AI intelligence through recursive self-improvement, came out of stealth and announced that it raised over $650 million in its Series A round at a $4.65 billion valuation. The funding round was led by Google Ventures and Greycroft, with participation from chip makers AMD Ventures and NVIDIA. Wilson Sonsini Goodrich & Rosati advised Recursive on the transaction.
Client Highlights
4.13.26
Wilson Sonsini Advises Elorian on $55 Million Seed Financing as Company Emerges from Stealth
On April 9, 2026, Palo Alto-based Elorian AI, a start-up building models for visual reasoning, emerged from stealth and announced a $55 million seed funding led by Striker Ventures, Menlo Ventures, and Altimeter. 49 Palms, prominent AI researchers, and other investors also participated in the round. Wilson Sonsini Goodrich & Rosati advised Elorian on the transaction.
Client Highlights
2.05.26
Wilson Sonsini Advises Adaption Labs on $50 Million Seed Funding
On February 4, 2026, Adaption Labs, a start-up building AI systems that evolve through real world interaction, enabling efficient AI across domains, languages, and operational constraints, announced it has raised $50 million in a seed funding round led by Emergence Capital Partners, with participation from Mozilla Ventures, Fifty Years, Threshold Ventures, Alpha Intelligence Capital, E14 Fund, and Neo. Wilson Sonsini Goodrich & Rosati advised Adaption Labs on the transaction.
Client Highlights
11.12.25
Wilson Sonsini Advises d-Matrix on Oversubscribed $275 Million Series C Funding
On November 12, 2025, d-Matrix, a pioneer in generative AI inference compute for data centers, announced an oversubscribed $275 million in Series C funding, valuing the company at $2 billion and bringing the total raised to date to $450 million. The funding is co-led by a global consortium that includes Bullhound Capital, Triatomic Capital, and Temasek. The round also includes new participation from the Qatar Investment Authority and EDBI, alongside follow-on participation from M12 (Microsoft’s venture fund), Nautilus Venture Partners, Industry Ventures, and Mirae Asset. Wilson Sonsini Goodrich & Rosati advised d-Matrix on the transaction.
Client Highlights
10.17.25
Wilson Sonsini Advises Sage Care on $20 Million Funding as Company Emerges from Stealth
On October 17, 2025, Sage Care, a platform designed to eliminate healthcare navigation inefficiencies through a combination of clinically intelligent AI agents and advanced optimization algorithms, announced its public launch with $20 million in funding led by Yosemite and continued support from General Catalyst, Metrodora, OVTR.VC, SV Angel, Liquid 2, Seven Stars, Refract Ventures, AME Cloud Ventures, and Apolo Ohno. Wilson Sonsini Goodrich & Rosati advised Sage Care on the transaction.
Client Highlights
10.01.25
Wilson Sonsini Advises Periodic Labs on $300 Million Seed Round
On September 30, 2025, Periodic Labs announced a $300 million Seed round led by Andreessen Horowitz. Additional participation came from Felicis, DST Global, NVIDIA, Accel, and individual investors including Elad Gil, Eric Schmidt, Jeff Dean, and Jeff Bezos. Wilson Sonsini Goodrich & Rosati advised Periodic Labs on the transaction.
Client Highlights
12.12.24
Wilson Sonsini Advises Axiado Corporation on $60 Million Series C Funding
On December 4, 2024, Axiado Corporation, a pioneer in hardware anchored platform security, announced it successfully raised $60 million in an oversubscribed Series C funding round. The round was led by Maverick Silicon with participation from Samsung Catalyst Fund, Atreides Management, and Crosslink Capital. Wilson Sonsini Goodrich & Rosati advised Axiado Corporation on the transaction.
This investment will fuel the company’s rapid growth and continued innovation in AI-driven cybersecurity technologies that are redefining platform security and energy efficiency for accelerated computing in AI data centers. Axiado will use the funding to drive continued innovation, strengthen strategic partnerships with leading platform vendors like NVIDIA, AMD, Intel, and Arm, and accelerate go-to-market initiatives with OEM and ODM partners to drive Axiado solutions into the data centers.
This investment will fuel the company’s rapid growth and continued innovation in AI-driven cybersecurity technologies that are redefining platform security and energy efficiency for accelerated computing in AI data centers. Axiado will use the funding to drive continued innovation, strengthen strategic partnerships with leading platform vendors like NVIDIA, AMD, Intel, and Arm, and accelerate go-to-market initiatives with OEM and ODM partners to drive Axiado solutions into the data centers.
Client Highlights
8.19.24
Wilson Sonsini Advises Neptune Medical on $97 Million Series D Financing
On August 15, 2024, Neptune Medical, a leader in medical device innovation, announced the completion of a $97 million Series D financing. Sonder Capital and Olympus Corporation of the Americas were significant participants in the round, which included investments from other existing and new investors. Wilson Sonsini Goodrich & Rosati advised Neptune Medical on the transaction.
The financing will strengthen Neptune Medical as a gastrointestinal-focused company expanding into robotics for GI disease, as evidenced by the recent appointment of medical robotics pioneer Dr. Fred Moll as chairman of the company’s board.
Neptune Medical also announced the successful spinout of its subsidiary, Jupiter Endovascular, which is developing a new class of endovascular procedures to bring the precision and control of direct surgical access to catheter-based interventions. Wilson Sonsini will represent Jupiter Endovascular moving forward.
The Wilson Sonsini team that advised Neptune Medical on the Series D financing included James Huie, Brian Appel, MJ Han, and Ryan Isola.
For more information, please see Neptune Medical’s news release. Additional coverage is available in Fierce Biotech.
The financing will strengthen Neptune Medical as a gastrointestinal-focused company expanding into robotics for GI disease, as evidenced by the recent appointment of medical robotics pioneer Dr. Fred Moll as chairman of the company’s board.
Neptune Medical also announced the successful spinout of its subsidiary, Jupiter Endovascular, which is developing a new class of endovascular procedures to bring the precision and control of direct surgical access to catheter-based interventions. Wilson Sonsini will represent Jupiter Endovascular moving forward.
The Wilson Sonsini team that advised Neptune Medical on the Series D financing included James Huie, Brian Appel, MJ Han, and Ryan Isola.
For more information, please see Neptune Medical’s news release. Additional coverage is available in Fierce Biotech.
Client Highlights
3.21.24
Wilson Sonsini Advises Orbillion on New Funding Round
On March 14, 2024, cultivated meat start-up Orbillion said it has raised fresh capital bringing its cumulative funding to $15 million. The round follows a successful 200-liter production run which the company says validates its predictive modeling platform for "de-risking" the scale-up process for cultivated meat. The round was led by The Venture Collective and co-led by At One Ventures, with participation from YCombinator, Metaplanet, and global food investors including university endowments and strategic investors, and follows a $5 million Seed round announced in 2021.
Client Highlights
1.23.24
Wilson Sonsini Advises Syrup on $17.5 Million Series A Financing
On December 1, 2023, Syrup Tech, a start-up that provides AI-powered planning, buying, and inventory optimization for omnichannel commerce, announced its $17.5 million Series A fundraise. The funding round is led by Accel with participation from existing investors Gradient Ventures and 1984 Ventures. Increased accuracy in forecasting takes the guesswork out of merchandise planning, helping reduce overproduction. Syrup connects inventory data with a unique mix of historical, transactional, and real-time data so that planning teams can make optimal decisions for their inventories. Wilson Sonsini Goodrich & Rosati advised Syrup Tech on the transaction.